Nvidia has returned 700% during the Age of AI, but smaller companies may have more room to run. Pfizer, Tesla, and Kroger are ...
A Pfizer Covid booster vaccination gave a fit 54-year-old chronic pain, NHS doctors found. Larry Lowe, from Omagh in Northern Ireland, has suffered steadily worsening pain since he received the ...
Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the covid-19 pandemic, is suddenly facing a new challenge from a large shareholder frustrated over ...
Mikael Backlund, the Calgary Flames captain, landed a controversial slash on the Edmonton Oilers' goalie Stuart Skinner during last night's Battle for Alberta. The Oilers aren't off to a great start ...
The Edmonton Oilers and their fans were left fuming at the end of the first period after Calgary Flames forward Mikael Backlund took some liberties with Oilers goaltender Stuart Skinner, with no ...
Starboard Value, an activist investing group, took a position in Pfizer. It will now proceed to lobby for new initiatives, or perhaps new company leaders. Some of the activist's potential ...
Jefferies analyst Akash Tewari maintained a Buy rating on Pfizer (PFE – Research Report) today and set a price target of $33.00. The company’s shares closed yesterday at $29.34. Tewari covers ...
The mes­sage over the week­end to Pfiz­er’s CEO Al­bert Bourla was blank. But it con­tained a warn­ing nonethe­less.
Albert Bourla was preparing for a board off-site in Ireland this Sunday, when the Pfizer chief executive opened his email inbox to see an unexpected message. The email from Frank D’Amelio, his former ...
Activist Starboard Value accused Pfizer of threatening litigation against two renegade former executives that initially were supportive of the investor's turnaround campaign at the pharmaceutical ...
Pfizer Threatened Ex-CEO Over Work With Activist, Starboard Says Allegations escalate activist investor’s turnaround campaign Starboard says it’s scheduled to meet with Bourla Oct. 16 ...
Pfizer’s situation with activist investor Starboard Value is already getting messy. Days before the fund is set to sit down with CEO Albert Bourla to pitch a new strategic path for the pharma ...